-
Unprofitable listed pharmaceutical companies pay attention! More than half of the product sales peak is less than this number!
Time of Update: 2021-03-05
in 2015, Sanofi and Regeneration jointly developed Arrocumab (Praluent), Amgen and Astellas launched the Iloyu single anti-injection Evolocumab (Repatha) has been approved for the market, and is considered to be an important target for heavy bomb drugs.
-
From "buy, buy" to "naturalized" listed pharmaceutical companies experienced what?
Time of Update: 2021-03-05
biology, Kangzhi Pharmaceuticals and other listed companies announced the sale of assets. Four Rings Bio announced on December 13, 2019 that its wholly-owned subsidiary Guangxi InterContinental Forestry Investment Co., Ltd. announced
-
Beida Pharmaceuticals is going to the Hong Kong Stock Exchange to list, and two more anti-cancer
Time of Update: 2021-03-04
cancer, ensartinib, in the second decade. this is a new powerful, highly selective new generation of APK inhibitors, by effectively inhibiting the activity of APK, to inhibit tumor growth. 2020, Nsatinib was approved for listing in China
-
The second batch of volume purchase lists flowed out of generic drugs to kill prices or more violently
Time of Update: 2021-03-04
/> As a result of this news, on November 29th, the share prices of Stone Pharmaceutical Group, Green Leaf Pharmaceuticals, Hengrui Pharmaceuticals and other related pharmaceutical companies fell sharply. "From the current information
-
Ji Pharmaceutical Holdings intends to acquire a 100% stake in Amended Pharmaceuticals, Jilin's richest man or shell listing
Time of Update: 2021-03-04
Pharmaceutical Holdings announced on the evening of July 10 that it intends to purchase a 100% stake in Amended Pharmaceutical Group Co., Ltd. through the issuance of shares. The transaction is expected to constitute a major asset
-
Yi Heng Health is listed on NASDAQ
Time of Update: 2021-03-03
According to the data disclosed in the prospecto, Yiheng Health's total revenue for 2018 was $199 million, up 103.1% YoY, and revenue for the first half of 2019 was $151 million, up 112.7% YoY.
-
Pfizer's long-acting growth hormone somatrogon filed for listing in Japan
Time of Update: 2021-03-03
two studies, after 12 months of treatment, somatrogon was comparable to Genotropin in terms of height growth rate in the main endpoint years.
-
Stone Pharmaceutical Group's application for the listing of anticancer drugs is to be included in the priority review
Time of Update: 2021-03-02
lipid body is the self-developed mitoxyquinone lipid system agent, is a 2.2 class of improved new drugs, stone pharmaceutical group has full intellectual property rights. In 2017, the FDA granted the drug orphan status for the treatment of external T
-
The four sub-centers of the State Drug Administration are listed
Time of Update: 2021-03-02
and the Medical Device Technical Review and Inspection Dawan Division Center were officially established in Shenzhen, which is a concrete action to implement the spirit of General Secretary Xi Jinping's important speech, and is an important initiative
-
Bayer's first sGC stimulant filed for listing in China
Time of Update: 2021-03-02
treatments can reduce these risks. With about 13.7 million heart failure patients in China, new treatments are urgently needed to help ease the burden of the disease. VICTORIA is a randomized, placebo-controlled, parallel group
-
China National Pharmaceutical Group submitted an application for the listing of the new crown vaccine
Time of Update: 2021-03-01
, deputy general manager of China National Pharmaceutical Group Co., Ltd., said China National Pharmaceutical Group has submitted a new crown vaccine listing application to the State Drug Administration.
-
2015 China's top paint list released Jiabao ranked first in the mainland
Time of Update: 2021-03-01
than 20 million yuan coating enterprises on the list. This is also the third year in a row that Tu Win World has released the list, much earlier than the previous two years. The top four are all international companies with a foreign
-
In 2015, the list of the first batch of failed companies was announced with 16 paint companies on the list
Time of Update: 2021-03-01
China Paint network : With the development of the times, social progress, the Internet quietly into our lives, become an indispensable part of our lives. People can communicate and shop through the Internet, which adds a lot of fun to people's
-
The net profit of 42 listed housing companies increased by only 5% in 2014 and declined by nearly 50%.
Time of Update: 2021-03-01
, of which 19 housing enterprises attributable to the parent company's shareholders' net profit fell, accounting for nearly 50 percent, which to a certain extent reflects the real estate industry's overall profit margin downward phenomenon.
-
Jiangmen 2015 new stainless steel mud knife lighting knife listed
Time of Update: 2021-02-28
The use of high-quality stainless steel materials, durable, can be used in diatom mud, texture coatings and other artistic coatings construction.
-
The list of experts in the "synthetic biology" key special review was published
Time of Update: 2021-02-28
in accordance with the "synthetic biology" key special evaluation work arrangements, the Biological Center will be October 29-31, 2019 to organize the "synthetic biology" key special 2019 declaration project defense review meeting
-
List of experts for the first round of evaluation of key special declaration projects
Time of Update: 2021-02-27
according to the key special evaluation work arrangement, the Biological Center organized the first round of the 2020 annual declaration project for synthetic biology from June 12 to June 18, 2020.
-
HNA investment to terminate major asset restructuring core medical assets listed and then stranded
Time of Update: 2021-02-27
to as UY Outpatient). same time, HNA's proposed targets for the deal include Beijing Haiyun Holiday Sports and Fitness Co., Ltd., a controlling stake in an overseas education group, Tianjin Derong Hospital Co., Ltd. and Tianjin Modern Harmony
-
Beda Pharmaceuticals listed two years of continuous decline in performance, trapped in the "one drug, one big" dilemma?
Time of Update: 2021-02-27
that this downward trend from 2017 to date. third-quarter results showed that Bayda Pharmaceuticals reported revenue of 928 million yuan in the first three quarters, up 20.74 percent from a year earlier, while net profit attributable
-
Multi-part space-time analysis: into a single-celled "society"
Time of Update: 2021-02-26
for chromatin DNA of living cells through the transformation of sgRNA, which enables long-term continuous observation and tracking of gene locations in living cells. 2018, this major project is a major breakthrough. Xie Xiaoliang's team
